戻る Agenda
Session 11 Track A: Case Study: A Health Literacy Approach to Improve the Understandability and Usability of Consumer Brief Summaries
Session Chair(s)
Michele Sharp, PharmD
Senior Director, Global Regulatory Affairs
Eli Lilly and Company, United States
Print pharmaceutical advertisements in the US require inclusion of a brief summary of side effects, warnings, and contraindications from the labeling. The full prescribing information, which sponsors have traditionally used to fulfill the brief summary requirement, does not adhere to health literacy best practices, limiting its value to consumers. Studies increasingly show that health information that adheres to health literacy best practices, and is tested with users, improves people’s comprehension and health behaviors. This session will focus on recent research to improve the understandability and usability of brief summaries with consumers.
Learning Objective : At the conclusion of this session, participants should be able to: - Identify what Health Literacy is and why it matters
- Describe the methodologies used to evaluate content in different design formats
- Gain insight on two evidence-based strategies to assess readability
- Discuss opportunities to integrate Health Literacy principles in other Ad Promo communications to consumers
Speaker(s)
Speaker
Lori Hall, BSN
Eli Lilly and Company, United States
Director, Global Health Literacy
Speaker
Linda Neuhauser, DrPH, MPH
University of California – Berkeley, School of Public Health, United States
Clinical Professor, Community Health Sciences